Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07386392
Eligibility Criteria:
Inclusion Criteria:
* Patient over the age of 18
* Patient diagnosed with acute myeloid leukemia in Western Occitanie
* Eligible for first-line induction chemotherapy with anthracycline and cytarabine
* Patient able to understand and respond to a self-administered questionnaire
* Affiliated with or beneficiary of a social security system
* Having signed the research consent form
Exclusion Criteria:
* Patients diagnosed with acute myeloid leukemia 3
* Patients who were treated in intensive care prior to hospitalization for induction therapy or following induction therapy
* Patients with a diagnosed chronic pain-inducing disease (e.g., rheumatoid arthritis), if not stable
* Patients with a confirmed diagnosis of psychopathology such as psychosis, depression, or burnout, if not stable
* Patients suffering from epilepsy, whether treated or not, or with a history of epilepsy
* Patients under guardianship, conservatorship, or legal protection
* Pregnant or breastfeeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07386392
Study Brief:
Protocol Section:
NCT07386392